Skip to main content
Daniel Rader, MD, Internal Medicine, Philadelphia, PA, Penn Presbyterian Medical Center

DanielJRaderMD

Internal Medicine • Philadelphia, PA

Preventive Medicine

Seymour Gray Professor of Molecular Medicine Chair, Department of Genetics Chief, Division of Translational Medicine and Human Genetics, Department of Medicine

Join to view full profile

Dr. Rader is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rader's full profile

Already have an account?

  • Office

    11-125 Smilow Center for Translational Research
    3400 Civic Center Blvd
    Philadelphia, PA 19104
    Phone+1 215-573-4176
  • Is this information wrong?

Education & Training

  • National Heart Lung and Blood Institute (NHLBI)
    National Heart Lung and Blood Institute (NHLBI)Post-Doctoral Fellowship, Lipid disorders, 1998 - 2003
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1984 - 1987
  • MCP-Hahnemann College of Medicine
    MCP-Hahnemann College of MedicineClass of 1984

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1993 - 2024
  • MD State Medical License
    MD State Medical License 1988 - 1995
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected member American Academy of Arts and Science, 2019
  • Top doctors Philadelphia Magazine, 2004-2019
  • Elected member National Academy of Medicine, 2011
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • The Present and Future JACC Scientific Expert Panel Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel  
    Joshua W Knowles, Seth J Baum, MacRae F Linton, Nathan O Stitziel, Daniel J Rader, Samuel S Gidding, Ray E Hershberger, Zahid S Ahmad, Christie M Ballantyne, ScienceDirect

Press Mentions

  • Penn Medicine, Philadelphia: $25 Million Gift Establishes Armellino Center of Excellence for Williams Syndrome at Penn Medicine
    Penn Medicine, Philadelphia: $25 Million Gift Establishes Armellino Center of Excellence for Williams Syndrome at Penn MedicineAugust 8th, 2022
  • Daniel J. Rader, M.D., FAHA, of the University of Pennsylvania, to Receive 2021 Research Achievement Award, the American Heart Association’s Highest Scientific Award
    Daniel J. Rader, M.D., FAHA, of the University of Pennsylvania, to Receive 2021 Research Achievement Award, the American Heart Association’s Highest Scientific AwardNovember 3rd, 2021
  • Genetic Variant Linked to HF in People of African American or Latino Ancestry
    Genetic Variant Linked to HF in People of African American or Latino AncestryDecember 13th, 2019
  • Join now to see all

Grant Support

  • Discovery And Validation Of Novel Loci Associated With HDL FunctionNational Heart, Lung, And Blood Institute2012
  • Molecular Regulation Of HDL Metabolism &Reverse Cholesterol TransportNational Heart, Lung, And Blood Institute2010–2012
  • HDL METABOLISM: Influence Of Extracellular LipasesNational Heart, Lung, And Blood Institute2009–2012
  • Genetics Of Elevated High Density Lipoprotein CholesterolNational Heart, Lung, And Blood Institute2008–2012
  • Effects Of Niacin On Lp(A), Oxidized LDL, And Inflammation In The Aim-High TrialNational Heart, Lung, And Blood Institute2008–2012
  • Ips-Derived Hepatocytes For Interrogation Of Lipid PhenotypesNational Human Genome Research Institute2011
  • Interrogation Of Novel Pathways Regulating VLDL Production And Plasma LipidsNational Heart, Lung, And Blood Institute2011
  • Gene Therapy For DyslipidemiasNational Heart, Lung, And Blood Institute2010–2011
  • Genetics Of Lipoprotein Metabolism And CVD In CKDNational Heart, Lung, And Blood Institute2009–2011
  • Molecular Mechanisms And Pathways Of Novel Genomic Loci Regulating Plasma LipidsNational Heart, Lung, And Blood Institute2009–2010
  • Identification Of Causal Variants At Novel GWAS Loci Associated With Lipid TraitsNational Heart, Lung, And Blood Institute2009–2010
  • Comprehensive Biomarker Study To Capitalize On Existing GWAS In 10K South AsiansNational Heart, Lung, And Blood Institute2009–2010
  • Markers Of The Metabolic Syndrome Linking Type 2 Diabetes And MI In South AsiaFogarty International Center2009–2010
  • Molecular Regulation Of HDL Metabolism And Reverse Cholesterol TransportNational Heart, Lung, And Blood Institute2009
  • HDL METABOLISM: Influence Of Extracellular LipasesNational Heart, Lung, And Blood Institute2009
  • High Density Lipoprotein Metabolism Influence Of Extracellular PhospholipasesNational Heart, Lung, And Blood Institute2007–2008
  • Gene Therapy For Dyslipidemia And AtherosclerosisNational Heart, Lung, And Blood Institute2004–2008
  • APOE And Regulation Of COX-2 In VsmcsNational Heart, Lung, And Blood Institute2004–2008
  • APO A-1 And Reverse Cholesterol Transport In VivoNational Heart, Lung, And Blood Institute2004–2007
  • HDL Metabolism Influence Of Extracellular PhospholipasesNational Heart, Lung, And Blood Institute2004–2006
  • Antioxidant And Anti-Inflammatory Mechanisms Of HDLNational Heart, Lung, And Blood Institute2003–2006
  • Mentored Career Development In Patient Oriented ResearchNational Center For Research Resources2002–2006
  • Orally Administered D-4F In Normal Healthy VolunteersNational Center For Research Resources2005
  • Microsomal Triglyceride Transfer Protein (MTP) Inhibitor Bms-201038National Center For Research Resources2005
  • Mechanism Of Pi-Related Dyslipidemia And Atherosclerosis In HIV SubjectsNational Center For Research Resources2005
  • Htg Implitapide StudyNational Center For Research Resources2005
  • Hofh Implitapide StudyNational Center For Research Resources2005
  • Hefh Implitapide StudyNational Center For Research Resources2005
  • Effects Of Rosiglitazone On HDL In Non-Diabetic Patients With Metabolic SyndromeNational Center For Research Resources2005
  • Hdl-Cholesterol And Inflammation And Oxidative StressNational Center For Research Resources2004–2005
  • A Mechanistic Study Of The Effects Of Rosiglitazone On HDL MetabolismNational Center For Research Resources2004–2005
  • Association Of Coronary Calcification With Genetic Markers For AtherosclerosisNational Center For Research Resources1997–2005
  • Abnormal Plasma Lipid Levels In Persons At Risk For Premature CHDNational Center For Research Resources1996–2005
  • Gordon Research Conference: Lipoprotein Metabolism 2004National Heart, Lung, And Blood Institute2004
  • Rosiglitazone On HDL In Non-Diabetic Patients With The Metabolic SyndromeNational Center For Research Resources2004
  • Mechanism Of Pi-Related Dyslipidemia And AtherosclerosisNational Center For Research Resources2004
  • Bms-201038 In Patients With Homozygous Familial HypercholesterolemiaNational Center For Research Resources2004
  • Mechanism Of Pi-Related Dyslipidemia And AtherosclerosisNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
  • APO A-1 And Reverse Cholesterol Transport In VivoNational Heart, Lung, And Blood Institute2003
  • HDL Metabolism:Influence Of Extracellular PhospholipasesNational Heart, Lung, And Blood Institute2000–2003
  • Antioxidant And Antiinflammatory Mechanisms Of HDLNational Heart, Lung, And Blood Institute2002
  • Soft Gel Containing Plant Stanol Esters To Help Reduce Total And LDL CholesterolNational Center For Research Resources2000–2002
  • Gene Therapy For Fh: Evaluation With Lipoprotein Kinetic StudiesNational Center For Research Resources2000–2002
  • Ex Vivo Gene Therapy For Familial HypercholesterolemiaNational Center For Research Resources2000–2002
  • Chronic Dosing Of Bms-201038 And Hepatic Fat Accumulation, And ReversibilityNational Center For Research Resources2000–2002
  • Gene Therapy Of AtherosclerosisNational Heart, Lung, And Blood Institute1999–2002
  • Cellular Basis Of Antiatherogenesis By Apolipoprotein ENational Heart, Lung, And Blood Institute1998–2001
  • Yogurt Containing Plant Stanol Esters To Help Reduce Total LDL ChlstrNational Center For Research Resources1999–2000
  • Effect Of Increasing Doses Of Micronized Fenofibrate On HypertriglycerimediaNational Center For Research Resources1999–2000
  • Gene Therapy For Fh--Evaluation With Lipoprotein Kinetic StudiesNational Center For Research Resources1997–1999
  • HDL Metabolism--Influence Of Spla2 And SAANational Heart, Lung, And Blood Institute1996–1998

Professional Memberships

Hospital Affiliations

Dr. Daniel Rader, Dr. Daniel Rader, MD, Dr. D Rader, Dr. Daniel J Rader